H.R. 1509 119th Congress
Accelerating Kids’ Access to Care Act of 2025
- Health
- Sponsor: Rep. Trahan, Lori [D-MA-3]
- Congress.gov ↗
Latest action, Feb 21, 2025: Referred to the House Committee on Energy and Commerce.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
104 cosponsors
Sponsored by Rep. Trahan, Lori [D-MA-3] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
69 D · 35 R
Referred to: House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
7 reports
7 reports
BOSTON CHILDREN'S HOSPITAL
FAEGRE DRINKER BIDDLE & REATH LLP
7 reports
7 reports
7 reports
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES
7 reports
6 reports
6 reports
6 reports
ORCHARD THERAPEUTICS NORTH AMERICA
LEAVITT PARTNERS, LLC
6 reports
5 reports
5 reports
5 reports
The top 25 of 49 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN HEART ASSOCIATION | 7 | $2.4M | Q1 2025 | Q3 2026 | yes | |
| AMERICAN LUNG ASSOCIATION | 7 | $1.1M | Q1 2025 | Q3 2026 | yes | |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | 7 | $2.8M | Q1 2025 | Q3 2026 | yes | |
| BOSTON CHILDREN'S HOSPITAL | FAEGRE DRINKER BIDDLE & REATH LLP | 7 | $190K | Q1 2025 | Q3 2026 | yes |
| DANA-FARBER CANCER INSTITUTE | 7 | $399K | Q1 2025 | Q3 2026 | yes | |
| NATIONAL ALLIANCE ON MENTAL ILLNESS | 7 | $90K | Q1 2025 | Q3 2026 | yes | |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) | NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES | 7 | $10.8M | Q1 2025 | Q3 2026 | yes |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 7 | $1.6M | Q1 2025 | Q3 2026 | yes | |
| ACADIA PHARMACEUTICALS | 6 | $3.6M | Q4 2025 | Q3 2026 | yes | |
| CHILDREN'S HOSPITAL BOSTON | 6 | $770K | Q1 2025 | Q2 2026 | yes | |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | 6 | $431K | Q4 2025 | Q3 2026 | yes | |
| ORCHARD THERAPEUTICS NORTH AMERICA | LEAVITT PARTNERS, LLC | 6 | $0 | Q4 2025 | Q3 2026 | yes |
| ALLIANCE FOR REGENERATIVE MEDICINE | 5 | $790K | Q1 2025 | Q1 2026 | yes | |
| AMERICAN ACADEMY OF PEDIATRICS | 5 | $1.3M | Q1 2025 | Q1 2026 | yes | |
| ASSOCIATION FOR CLINICAL ONCOLOGY | 5 | $1.3M | Q1 2025 | Q1 2026 | yes | |
| BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) | KOUNTOUPES DENHAM CARR & REID, LLC | 5 | $300K | Q1 2025 | Q1 2026 | yes |
| CHILDREN'S HOSPITAL COLORADO | FAEGRE DRINKER BIDDLE & REATH LLP | 5 | $150K | Q1 2025 | Q1 2026 | yes |
| CLEVELAND CLINIC FOUNDATION | THE NICKLES GROUP, LLC | 5 | $0 | Q1 2025 | Q1 2026 | yes |
| CURE SMA | 5 | $375K | Q4 2025 | Q3 2026 | yes | |
| NATIONAL MARROW DONOR PROGRAM | 5 | $1.5M | Q1 2025 | Q1 2026 | yes | |
| PRAXIS PRECISION MEDICINES | THE KPM GROUP DC LLC | 5 | $200K | Q1 2025 | Q1 2026 | yes |
| RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) | FAEGRE DRINKER BIDDLE & REATH LLP | 5 | $0 | Q1 2025 | Q1 2026 | yes |
| RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) | 5 | $220K | Q1 2025 | Q1 2026 | yes | |
| THE SOCIETY OF THORACIC SURGEONS | 5 | $1.1M | Q1 2025 | Q1 2026 | yes | |
| ALLIANCE FOR REGENERATIVE MEDICINE | AVENUE SOLUTIONS | 4 | $0 | Q1 2025 | Q3 2025 | yes |